Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "Dwilewicz-Trojaczek, Jadwiga" wg kryterium: Autor


Wyświetlanie 1-2 z 2
Tytuł:
IgM multiple myeloma: diagnostic difficulties and results of bortezomib treatment – case report
Autorzy:
Machowicz, Rafał
Skwierawska, Kamila
Mądry, Krzysztof
Górka, Michał
Żurawska, Jagoda
Kacprzyk, Piotr
Waszczuk-Gajda, Anna
Dwilewicz-Trojaczek, Jadwiga
Powiązania:
https://bibliotekanauki.pl/articles/773502.pdf
Data publikacji:
2014
Wydawca:
Medical Education
Tematy:
IgM
Waldenström’s macroglobulinemia
bortezomib
multiple myeloma
Opis:
The IgM paraprotein secretion is most frequently associated with Waldenström’s macroglobulinemia. In very rare cases it may also occur in multiple myeloma. The diagnostic and therapeutic process of a 84 year old male suffering from IgM multiple myeloma is described, including difficulties in establishing this diagnosis. Due to infectious complications, after the first cycle of melphalan– prednisone–bortezomib treatment, melphalan was stopped, subsequently, bortezomib and prednisone doses were also reduced. Two treatment interruptions have occurred. Despite reduced treatment intensity, the patient was in very good partial remission, while the toxicity profile was acceptable. IgM multiple myeloma should be included in the differential diagnosis of IgM paraproteinemia, also when osteolytic lesions and translocation 11:14 are not detected. Bortezomib-based therapy can be effective in elderly patients (also in those suffering from cardiac insufficiency), even when dose reduction is required.
Źródło:
OncoReview; 2014, 4, 4; A160-A164
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Post-transplant care after allogeneic hematopoietic stem cell transplantation
Autorzy:
Karakulska-Prystupiuk, Ewa
Dwilewicz-Trojaczek, Jadwiga
Powiązania:
https://bibliotekanauki.pl/articles/1065069.pdf
Data publikacji:
2015
Wydawca:
Medical Education
Tematy:
hematopoietic stem cell transplantation
post-transplant care
post-transplant complications
Opis:
Around 25,000 people annually worldwide are subject to the procedure of allogeneic hematopoietic stem cell transplantation (HSCT). As the number of procedures has been on the rise, post-transplant care is becoming an essential part of work at transplant centres and general practitioners’ offices. Advances in technology and supportive therapies extend long-term survival of patients after HSCT, which increases the risk of complications resulting from exposure before, during and after transplant procedures. The complications may lead to significant morbidity, deteriorated quality of life, and late mortality in patients who have received hematopoietic stem cells. Statistical analyses have shown that the survival rate of post-HSCT patients is ca. 30% lower than expected, and that infections, organ failure and secondary cancers lead to mortality in this population of patients.
Źródło:
OncoReview; 2015, 5, 1; A33-A41
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies